Evidence map›Paper›PMID 32423956›Full record

ArticleAntimicrobial agents and chemotherapy2020

Analysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal Peritonitis.

Ariane Roujansky, Victoire de Lastours, François Guérin, Françoise Chau, Geoffrey Cheminet, Laurent Massias, Vincent Cattoir, Bruno Fantin

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Ceftazidime retainsmSphere · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ariane RoujanskyIAME UMR-1137, INSERM, Paris, France.
Victoire de LastoursIAME UMR-1137, INSERM, Paris, France.
François GuérinCHU de Caen, Service de Microbiologie, Caen, France.
Françoise ChauIAME UMR-1137, INSERM, Paris, France.
Geoffrey CheminetIAME UMR-1137, INSERM, Paris, France.
Laurent MassiasIAME UMR-1137, INSERM, Paris, France.
Vincent CattoirCHU de Rennes, Service de Bactériologie-Hygiène Hospitalière & CNR de la Résistance aux Antibiotiques (laboratoire associé "Entérocoques"), Rennes, France.ORCID 0000-0003-4026-9912
Bruno FantinIAME UMR-1137, INSERM, Paris, France bruno.fantin@aphp.fr.
Inserm · FRCentre Hospitalier Universitaire de Caen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical benefit of carbapenems against carbapenemase-producing

Indexed as

Carbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsPeritonitisAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDisease Models, AnimalEscherichia coliMiceMice, Inbred ICRMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsantibiotic resistancecarbapenemasecarbapenemsEscherichia coliperitonitis

Identifiers

PMID32423956
PMCPMC7526833
OpenAlexW3025464550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.